Harms of Continued Antihypertensives: An Overview of Reviews

Carmen Floriani1, Angela Edith Schulthess-Lisibach2, Martina Zangger2

  • 1Institute of Primary Health Care (BIHAM), University of Bern, Mittelstrasse 43, 3012, Bern, Switzerland. carmen.floriani@unibe.ch.

Drugs & Aging
|March 12, 2026
PubMed

Insights

Antihypertensive drugs effectively treat high blood pressure and reduce cardiovascular risks. However, this review found they have various side effects, including dry cough and renal issues, requiring careful consideration.

Area of Science:

  • Pharmacology
  • Geriatrics
  • Cardiovascular Medicine

Background:

  • Hypertension is a major cardiovascular risk factor, with stricter blood pressure management recommended for older adults.
  • Antihypertensive medications are crucial for managing hypertension and reducing cardiovascular morbidity.
  • Evidence on specific harm outcomes of antihypertensive treatment is limited, posing challenges in clinical practice.

Purpose of the Study:

  • To systematically review and summarize evidence on the harms associated with continued antihypertensive treatment.
  • To focus on the older population to understand treatment-related risks in this demographic.

Main Methods:

  • Conducted a comprehensive search of systematic reviews in Ovid MEDLINE, Ovid Embase, and the Cochrane Library.
  • Included systematic reviews of randomized and non-randomized controlled trials on antihypertensive drug harms, excluding other article types.
  • Focused the analysis on studies pertaining to the older population.

Main Results:

  • The review identified 47 eligible systematic reviews from an initial search of 6353 items.
  • Commonly reported side effects include respiratory symptoms (e.g., dry cough with ACE inhibitors), hypotension, renal failure, and electrolyte imbalances.
  • These findings highlight a broad spectrum of potential adverse events associated with antihypertensive therapies.

Conclusions:

  • Antihypertensive drugs are effective in managing hypertension and mitigating cardiovascular disease.
  • Despite their benefits, a wide range of side effects necessitates careful patient monitoring and individualized treatment strategies.
  • Further research into specific harm outcomes is warranted to optimize antihypertensive therapy, particularly in older adults.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
807
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
696
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.7K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.9K